Form 8-K - Current report:
SEC Accession No. 0001564590-22-013497
Filing Date
2022-04-05
Accepted
2022-04-05 07:02:07
Documents
13
Period of Report
2022-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K MEDIDATA MATERIAL AGREEMENT pstv-8k_20220331.htm   iXBRL 8-K 36206
2 EX-99.1 pstv-ex991_6.htm EX-99.1 18119
  Complete submission text file 0001564590-22-013497.txt   190005

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220331.xsd EX-101.SCH 5725
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220331_lab.xml EX-101.LAB 19426
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220331_pre.xml EX-101.PRE 11610
7 EXTRACTED XBRL INSTANCE DOCUMENT pstv-8k_20220331_htm.xml XML 3550
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 22805165
SIC: 3841 Surgical & Medical Instruments & Apparatus